Syndromic congenital myelofibrosis associated with a loss-of-function variant in RBSN
Document Type
Accepted ManuscriptPublication Date
2018-05-21Keywords
Cell BiologyCellular and Molecular Physiology
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hematology
Hemic and Immune Systems
Hemic and Lymphatic Diseases
Metadata
Show full item recordAbstract
The human proteins rabenosyn-5 and VPS45 form a complex that plays a key role in early endocytosis. Pathogenic variants in VPS45 cause severe congenital neutropenia (SCN) with impaired neutrophil function, reticulin fibrosis of the bone marrow, and extramedullary hematopoiesis (OMIM: 615285). Patients with a specific VPS45 variant (p.Glu238Lys) also have intellectual disability and bilateral optic nerve hypoplasia. To date, the only evidence of a potential role for RBSN in human disease is the report of a homozygous missense variant (p.Gly425Arg) in a patient with intellectual disability, seizures, microcephaly, osteopenia, mild reticulin fibrosis of the bone marrow, and transient neutropenia.Source
Blood. 2018 May 21. pii: blood-2017-12-824433. doi: 10.1182/blood-2017-12-824433. [Epub ahead of print] Link to article on publisher's site
DOI
10.1182/blood-2017-12-824433Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29360PubMed ID
29784638Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
Rights
Copyright © 2018 American Society of Hematology. Accepted manuscript posted after 12 months as allowed by the publisher's author rights policy at http://www.bloodjournal.org/page/authors/copyright-information.ae974a485f413a2113503eed53cd6c53
10.1182/blood-2017-12-824433
